+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Prostate Cancer Market and Competitive Landscape - 2020

  • ID: 5023461
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Prostate Cancer Market and Competitive Landscape - 2020, provides comprehensive insights into the Prostate Cancer pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Prostate Cancer market size and drug sales. It also provides insights into Prostate Cancer epidemiology and late stage pipeline.

This research covers the following: Prostate Cancer treatment options, Prostate Cancer late stage clinical trials pipeline, Prostate Cancer prevalence by countries, Prostate Cancer market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Prostate Cancer pipeline: Find out drugs in clinical trials for the treatment of Prostate Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Prostate Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Prostate Cancer by countries
  • Prostate Cancer drugs: Identify key drugs marketed and prescribed for Prostate Cancer in the US, including trade name, molecule name, and company
  • Prostate Cancer drugs sales: Find out the sales value for Prostate Cancer drugs by countries
  • Prostate Cancer market valuations: Find out the market size for Prostate Cancer drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Prostate Cancer drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Prostate Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Prostate Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze Prostate Cancer drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Prostate Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Prostate Cancer Treatment Options

2. Prostate Cancer Pipeline Insights
2.1. Prostate Cancer Phase 3 Clinical Trials
2.2. Prostate Cancer Phase 2 Clinical Trials
2.3. Prostate Cancer Phase 1 Clinical Trials

3. Prostate Cancer Epidemiology Analysis by Countries

4. Germany Prostate Cancer Market Insights
4.1. Marketed Drugs for Prostate Cancer in Germany
4.2. Germany Prostate Cancer Market Size & Forecast
4.3. Germany Prostate Cancer Drugs Sales Forecast
4.4. Germany Prostate Cancer Market Share Analysis

5. France Prostate Cancer Market Insights
5.1. Marketed Drugs for Prostate Cancer in France
5.2. France Prostate Cancer Market Size & Forecast
5.3. France Prostate Cancer Product Sales Forecast
5.4. France Prostate Cancer Market Share Analysis

6. Italy Prostate Cancer Market Insights
6.1. Marketed Drugs for Prostate Cancer in Italy
6.2. Italy Prostate Cancer Market Size & Forecast
6.3. Italy Prostate Cancer Product Sales Forecast
6.4. Italy Prostate Cancer Market Share Analysis

7. Spain Prostate Cancer Market Insights
7.1. Marketed Drugs for Prostate Cancer in Spain
7.2. Spain Prostate Cancer Market Size & Forecast
7.3. Spain Prostate Cancer Product Sales Forecast
7.4. Spain Prostate Cancer Market Share Analysis

8. UK Prostate Cancer Market Insights
8.1. Marketed Drugs for Prostate Cancer in UK
8.2. UK Prostate Cancer Market Size & Forecast
8.3. UK Prostate Cancer Product Sales Forecast
8.4. UK Prostate Cancer Market Share Analysis

9. Europe Prostate Cancer Market Insights
9.1. Europe Prostate Cancer Market Size & Forecast
9.2. Europe Prostate Cancer Product Sales Forecast
9.3. Europe Prostate Cancer Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Prostate Cancer Phase 3 Clinical Trials, Global, 2020
Table 2: Prostate Cancer Phase 2 Clinical Trials, Global, 2020
Table 3: Prostate Cancer Phase 1 Clinical Trials, Global, 2020
Table 4: Prostate Cancer Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Prostate Cancer in Germany, 2019
Table 6: Germany Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Prostate Cancer Product Sales ($mn), 2016 - 2024
Table 8: Germany Prostate Cancer Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Prostate Cancer in France, 2019
Table 10: France Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Prostate Cancer Product Sales ($mn), 2016 - 2024
Table 12: France Prostate Cancer Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Prostate Cancer in Italy, 2019
Table 14: Italy Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Prostate Cancer Product Sales ($mn), 2016 - 2024
Table 16: Italy Prostate Cancer Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Prostate Cancer in Spain, 2019
Table 18: Spain Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Prostate Cancer Product Sales ($mn), 2016 - 2024
Table 20: Spain Prostate Cancer Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Prostate Cancer in UK, 2019
Table 22: UK Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Prostate Cancer Product Sales ($mn), 2016 - 2024
Table 24: UK Prostate Cancer Market Events and Trends, 2016 - 2024
Table 25: Europe Prostate Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Prostate Cancer Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Prostate Cancer Pipeline by Phase (%), Global, 2020
Figure 2: Prostate Cancer Prevalence by Countries, 2016 - 2024
Figure 3: Germany Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 4: Germany Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 5: Germany Prostate Cancer Market Share by Drugs (%), 2019
Figure 6: Germany Prostate Cancer Market - Future Market Share (%), 2024
Figure 7: France Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 8: France Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 9: France Prostate Cancer Market Share by Drugs (%), 2019
Figure 10: France Prostate Cancer Market - Future Market Share (%), 2024
Figure 11: Italy Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 12: Italy Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 13: Italy Prostate Cancer Market Share by Drugs (%), 2019
Figure 14: Italy Prostate Cancer Market - Future Market Share (%), 2024
Figure 15: Spain Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 16: Spain Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 17: Spain Prostate Cancer Market Share by Drugs (%), 2019
Figure 18: Spain Prostate Cancer Market - Future Market Share (%), 2024
Figure 19: UK Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 20: UK Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 21: UK Prostate Cancer Market Share by Drugs (%), 2019
Figure 22: UK Prostate Cancer Market - Future Market Share (%), 2024
Figure 23: Europe Prostate Cancer Market Size ($mn), 2016 - 2024
Figure 24: Europe Prostate Cancer Product Sales ($mn), 2016 - 2024
Figure 25: Europe Prostate Cancer Market Share by Drugs (%), 2019
Figure 26: Europe Prostate Cancer Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll